Πρωτεύουσες καρτέλες
Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.
Immunomodulatory Effects of Colistin on Host Responses against Carbapenem-resistant Klebsiella pneumoniae Biofilms..
Int J Antimicrob Agents. 106182.
(2020).
Epstein-Barr Encephalitis in a Child with Congenital Human Immunodeficiency Virus Infection: A Case Report Calling for No Forgetfulness..
Curr HIV Res. 18(1), 63-66.
(2020).
Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area..
J Glob Antimicrob Resist. 20, 214-218.
(2020).
Implementation of the Greek national immunization program among nursery attendees in the urban area of Thessaloniki..
Hippokratia. 23(4), 147-153.
(2019).
Thiamine Deficiency in a Child with Short Bowel Syndrome and Review..
Pediatr Gastroenterol Hepatol Nutr. 22(5), 493-499.
(2019).
Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care..
Microb Drug Resist. 25(9), 1347-1356.
(2019).
Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit..
Acta Paediatr. 108(10), 1923-1924.
(2019).
Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit..
Mol Biol Rep. 46(3), 3497-3500.
(2019).
Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms..
Antimicrob Agents Chemother. 63(3),
(2019).
Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit..
Microb Drug Resist. 25(5), 712-716.
(2019).
Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis..
Pediatr Infect Dis J. 38(1), 42-49.
(2019).
Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria..
J Infect. 77(5), 448-454.
(2018).
Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients..
Antimicrob Agents Chemother. 62(6),
(2018).
Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data..
Eur J Clin Microbiol Infect Dis. 37(7), 1211-1220.
(2018).
Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care..
J Hosp Infect. 99(4), 396-404.
(2018).
Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria..
J Pediatric Infect Dis Soc. 6(2), 123-128.
(2017).
Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department..
Transpl Infect Dis. 19(3),
(2017).
Isavuconazole: an azole active against mucormycosis..
Lancet Infect Dis. 16(7), 761-762.
(2016).
Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence..
Acta Neurochir (Wien). 158(9), 1647-54.
(2016).
A Rare Case of Clavicle Osteomyelitis in a Child and Literature Review..
Case Rep Pediatr. 2016, 8252318.
(2016).
A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman..
Case Rep Infect Dis. 2016, 9629761.
(2016).
Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit..
Eur J Pediatr. 174(1), 65-74.
(2015).
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms..
J Antimicrob Chemother. 70(2), 470-8.
(2015).
Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa..
Antimicrob Agents Chemother. 59(4), 2198-205.
(2015).